The contact system in liver injury.

Abstract

Coagulation is controlled by a delicate balance of prothrombotic and antithrombotic mechanisms, to prevent both excessive blood loss from injured vessels and pathologic thrombosis. The liver plays a pivotal role in hemostasis through the synthesis of plasma coagulation factors and their inhibitors that, in addition to thrombosis and hemostasis, orchestrates an array of inflammatory responses. As a result, impaired liver function has been linked with both hypercoagulability and bleeding disorders due to a pathologic balance of pro- and anticoagulant plasma factors. At sites of vascular injury, thrombus propagation that finally may occlude the blood vessel depends on negatively charged biopolymers, such as polyphosphates and extracellular DNA, that provide a physiological surface for contact activation of coagulation factor XII (FXII). FXII initiates the contact system that drives both the intrinsic pathway of coagulation, and formation of the inflammatory mediator bradykinin by the kallikrein-kinin system. Moreover, FXII facilitates receptor-mediated signalling, thereby promoting mitogenic activities, angiogenesis, and neutrophil stimulation with implications for liver diseases. Here, we summarize current knowledge on the FXII-driven contact system in liver diseases and review therapeutic approaches to target its activities during impaired liver function.

• Authors: Chandini Rangaswamy, Reiner K Mailer, Hanna Englert, Sandra Konrath, Thomas Renné
• Journal: Seminars in immunopathology (Semin Immunopathol) Vol. 43 Issue 4 Pg. 507-517 (08 2021) ISSN: 1863-2300 [Electronic] Germany
• PMID: 34125270 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2021. The Author(s).

Chemical References

• Factor XII

Topics

• Blood Coagulation
• Factor XII (metabolism)
• Humans
• Kallikrein-Kinin System
• Liver (metabolism)
• Thrombosis (etiology)